| Literature DB >> 30458246 |
Phuc Le1, Alexander Chaitoff2, Michael B Rothberg3, Arthur McCullough4, Niyati M Gupta3, Naim Alkhouri5.
Abstract
Type 2 diabetes (T2D) affects more than 9% of U.S. adults.1 Nonalcoholic fatty liver disease (NAFLD) has been recognized as a common co-morbidity in T2D. However, most previous epidemiologic studies have been subject to ascertainment and selection bias or had small sample sizes. No recent studies have examined trends of the burden of NAFLD in diabetic patients. Using noninvasive scores and the National Health and Nutrition Examination Survey (NHANES), we aimed to estimate the population-based trends in prevalence of NAFLD-associated comorbidities in U.S. adults with T2D.Entities:
Mesh：
Year: 2018 PMID： 30458246 DOI： 10.1016/j.cgh.2018.11.023
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN： 1542-3565 Impact factor: 11.382